Project Grant R43AT012449
Award Date
9/17/24
Completion Date
8/31/25
Dollars Obligated
$296K
Federal Agency
National Center for Complementary and Integrative Health
Awardee
Nemalife Inc. (JPKVJPK1ZYF2)
Federal Grant Program
93.213
Assistance Type
Project Grant
Place of Performance
Texas, USA
Similar Awards
This Project Grant award from the National Center for Complementary and Integrative Health (NCCIH) under CFDA 93.213 - Research and Training in Complementary and Integrative Health provides $451,000.00 in funding to The Trustees of Princeton University from September 2024 to August 2026. The objective is to characterize the secondary metabolomes of three Corynebacterial strains, including uncovering the small molecule products they use to compete with other microbes and interact with host cells....
This Project Grant award from the National Center for Complementary and Integrative Health (NCCIH) under CFDA Program 93.213 - Research and Training in Complementary and Integrative Health, provides $506,000.00 in funding to the Scripps Research Institute in La Jolla, CA from September 13, 2024 to August 31, 2026. The award supports research to develop orally available recombinant peptidoglycan hydrolase therapeutics that can promote intestinal barrier function and protect against enteric...
This federal Project Grant award from the National Center for Complementary and Integrative Health (NCCIH), under the Research and Training in Complementary and Integrative Health program (CFDA 93.213), provides $340,449 to Brown University to conduct research aimed at alleviating antibiotic-induced disruption of the gut microbiome. The project will use an ex vivo microbiome culture approach to test endogenous redox sinks and small molecule regulators as modulators of antibiotic-induced...
This federal Project Grant award of $854,736 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) aims to develop robust statistical methods for analyzing longitudinal microbiome studies. The grant funds the development of statistical tools to address key challenges in longitudinal microbiome research, including: (1) addressing batch effects, (2) identifying taxa associated with biomedical exposures or outcomes over time,...
The National Center for Complementary and Integrative Health (NCCIH) awarded a $822,442 Project Grant under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to North Carolina State University. The grant supports a 2-year research project to discover new terpene synthases and carotenoid-modifying enzymes within the human gut microbiome using a novel phage-based functional metagenomics approach. The project aims to characterize the products of these enzymes...
This $325,139 federal Project Grant award, funded by the National Center for Advancing Translational Sciences (NCATS), 93.350 program, aims to examine the feasibility of using target-specific polyclonal antibodies to neutralize bioactive molecules in the gut microbiome. The primary goals are to 1) determine the impact of six proteins identified as overabundant in inflammatory gut disorders, and 2) evaluate the ability of immunoglobulin Y (IgY) antibodies to neutralize the physiological impacts...
This $650,000 Project Grant awarded by the National Center for Advancing Translational Sciences (NCATS), under CFDA Program 93.350, supports research and development for a next generation probiotics-based platform technology to enable oral delivery of peptide and protein therapeutics. Specifically, the project aims to (1) develop an antibiotic-resistance-free expression system for stable, high-level production of therapeutic peptides in Lactobacillus probiotic strains, (2) create inducible...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to enhance the colonization of the probiotic bacterium E. coli Nissle 1917 (ECN) using CRISPR-Cas immunity. The $548,802 award, provided to Ancilia Biosciences Inc., will investigate how phage predation can limit the engraftment and therapeutic efficacy of live biotherapeutic products...
The National Institute of General Medical Sciences (NIGMS) awarded a $1,338,750 Project Grant to Yale University to conduct research on how gut bacteria can influence host feeding behavior and microbiome assembly using the roundworm Caenorhabditis elegans as a model system. The project aims to develop tools and assays to study the molecular mechanisms by which gut microbes can manipulate host feeding decisions, with the goal of gaining insights that may apply to other host-microbe systems. Key...
This $349,759 Project Grant awarded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to develop the world's first probiotic product specifically designed for the unique gastrointestinal tract of preterm infants. The project will expand upon a patented encapsulation technology to improve the gastric stability and shelf-life of probiotic strains Lactobacillus rhamnosus HN001 and...